BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27605671)

  • 1. Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.
    Zhang LK; Xin QL; Zhu SL; Wan WW; Wang W; Xiao G
    J Virol; 2016 Nov; 90(22):10259-10270. PubMed ID: 27605671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses.
    Koma T; Huang C; Kolokoltsova OA; Brasier AR; Paessler S
    J Mol Biol; 2013 Dec; 425(24):4893-903. PubMed ID: 24075870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
    Mateer EJ; Maruyama J; Card GE; Paessler S; Huang C
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
    Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
    J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
    Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arenaviral Nucleoproteins Suppress PACT-Induced Augmentation of RIG-I Function To Inhibit Type I Interferon Production.
    Shao J; Huang Q; Liu X; Di D; Liang Y; Ly H
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production.
    Xing J; Ly H; Liang Y
    J Virol; 2015 Mar; 89(5):2944-55. PubMed ID: 25552708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
    Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
    J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.
    Vera-Otarola J; Solis L; Lowy F; Olguín V; Angulo J; Pino K; Tischler ND; Otth C; Padula P; López-Lastra M
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
    J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
    Carnec X; Mateo M; Page A; Reynard S; Hortion J; Picard C; Yekwa E; Barrot L; Barron S; Vallve A; Raoul H; Carbonnelle C; Ferron F; Baize S
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-species analysis of the replication complex of Old World arenaviruses reveals two nucleoprotein sites involved in L protein function.
    Kerber R; Rieger T; Busch C; Flatz L; Pinschewer DD; Kümmerer BM; Günther S
    J Virol; 2011 Dec; 85(23):12518-28. PubMed ID: 21917982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus.
    Wang Q; Xin Q; Shang W; Wan W; Xiao G; Zhang LK
    Viruses; 2021 May; 13(6):. PubMed ID: 34070281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
    Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions.
    Huang Q; Shao J; Lan S; Zhou Y; Xing J; Dong C; Liang Y; Ly H
    J Virol; 2015 Jul; 89(13):6595-607. PubMed ID: 25878103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.